Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

GARY LEE PATTEE

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1396794749
CMS profile
63385
Location
LINCOLN, NE

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$16,507.16

96 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

By paying entity

PY2021 · entire year · sorted by reported total

Page 2 of 2; records 51–96 of 96 matching records. This page contains 46 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

GARY LEE PATTEE

NPI 1396794749 · CMS profile ID 63385

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology

LINCOLN, NE

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–96 of 96 matching records. This page contains 46 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1396794749?year=2021&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
GARY LEE PATTEE, NPI 1396794749, CMS profile ID 63385. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–96 of 96 matching records. This page contains 46 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1396794749?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). GARY LEE PATTEE, NPI 1396794749, CMS profile ID 63385. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–96 of 96 matching records. This page contains 46 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1396794749?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
GARY LEE PATTEE, NPI 1396794749, CMS profile ID 63385, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–96 of 96 matching records. This page contains 46 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1396794749?year=2021&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

96 matching records · $16,507.16 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 96 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–96 of 96.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Avanir Pharmaceuticals, Inc. $13.4805/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 801030683 CMS
Medtronic, Inc. $14.9505/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815779111 CMS
AbbVie Inc. $26.4605/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795563907 CMS
Zogenix Inc. $27.6805/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 854235245 CMS
Genentech USA, Inc. $23.0005/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 835913495 CMS
Genentech USA, Inc. $21.1005/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 835913499 CMS
GENZYME CORPORATION $14.3205/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843439015 CMS
Neurelis, Inc. $10.2505/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842875567 CMS
ARBOR PHARMACEUTICALS, INC. $15.1405/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830922441 CMS
Amgen Inc. $15.6404/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825322087 CMS
ACADIA Pharmaceuticals Inc $15.6904/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838014891 CMS
Adamas Pharmaceuticals, Inc. $15.5904/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834402873 CMS
Biogen, Inc. $20.3404/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827835303 CMS
AbbVie Inc. $5.0004/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795563901 CMS
Biohaven Pharmaceuticals, Inc. $56.7604/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852588121 CMS
MITSUBISHI TANABE PHARMA AMERICA, INC. $9.5104/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 844022979 CMS
Janssen Pharmaceuticals, Inc $15.9904/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788194279 CMS
MITSUBISHI TANABE PHARMA AMERICA, INC. $550.0004/09/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 844025067 CMS
Biogen, Inc. $20.4804/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827835297 CMS
Genentech USA, Inc. $19.9804/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 835913493 CMS
Neurelis, Inc. $18.4003/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842875565 CMS
Sarepta Therapeutics, Inc. $22.8103/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838083961 CMS
Eisai Inc. $20.9303/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 817870819 CMS
JAZZ PHARMACEUTICALS INC. $16.4003/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845600917 CMS
Supernus Pharmaceuticals, Inc. $19.2203/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845095758 CMS
Alexion Pharmaceuticals, Inc. $13.1603/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783125267 CMS
Acorda Therapeutics, Inc $16.0703/15/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792556103 CMS
Novartis Pharmaceuticals Corporation $22.3003/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813153799 CMS
Genentech USA, Inc. $15.3603/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 835913487 CMS
Avanir Pharmaceuticals, Inc. $13.2303/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 801040765 CMS
Neurelis, Inc. $19.6003/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842875561 CMS
GE HEALTHCARE $16.7203/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 837877463 CMS
AbbVie Inc. $18.3103/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795563895 CMS
Novartis Pharmaceuticals Corporation $11.7603/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813153803 CMS
Biogen, Inc. $11.3402/25/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827835295 CMS
Adamas Pharmaceuticals, Inc. $19.1902/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834402871 CMS
Genentech USA, Inc. $19.8602/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 835913489 CMS
UCB, Inc. $23.7402/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 807321341 CMS
AbbVie Inc. $16.0202/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795563889 CMS
Lundbeck LLC $20.7502/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845927785 CMS
ACADIA Pharmaceuticals Inc $21.1301/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838014887 CMS
Almatica Pharma LLC $24.5301/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842219965 CMS
CATALYST PHARMACEUTICALS, INC. $1,750.0001/23/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 828333279 CMS
Kyowa Kirin, Inc. $11.9401/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852990427 CMS
MITSUBISHI TANABE PHARMA AMERICA, INC. $56.9101/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 844024089 CMS
Avanir Pharmaceuticals, Inc. $11.1801/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 801046597 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $8,941.21 108
PY2020 $5,405.30 77
PY2021 $16,507.16 96
PY2022 $15,923.49 108
PY2023 $63,554.99 199
PY2024 $18,456.85 130
PY2025 $2,860.63 100

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $36,457.60 6
PY2024 Principal investigator $116,319.14 35
PY2023 Principal investigator $175,446.43 23
PY2022 Principal investigator $363,671.78 18
PY2021 Recipient $3,379.03 1
PY2021 Principal investigator $632,358.43 20
PY2020 Principal investigator $695,001.45 37
PY2019 Recipient $3,350.01 1
PY2019 Principal investigator $205,804.11 61

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

6 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 PTC Therapeutics, Inc. $6,790.76 04/18/2025 Non-covered Recipient Entity
GSR ENTERPRISES INC
A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL STUDY TO ASSESS THE EFFICACY, SAFETY, TOLERABILITY, PK, AND BIOMARKER EFFECTS OFPTC857IN ADULT SUBJECTS WITHAMYOTROPHIC LATERAL SCLEROSIS(CARDINALS) No dispute reported 06/30/2026 1249093339
Principal investigator 1 PTC Therapeutics, Inc. $703.17 02/27/2025 Non-covered Recipient Entity
GSR ENTERPRISES INC
A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL STUDY TO ASSESS THE EFFICACY, SAFETY, TOLERABILITY, PK, AND BIOMARKER EFFECTS OFPTC857IN ADULT SUBJECTS WITHAMYOTROPHIC LATERAL SCLEROSIS(CARDINALS) No dispute reported 06/30/2026 1249093245
Principal investigator 1 PTC Therapeutics, Inc. $350.00 02/18/2025 Non-covered Recipient Entity
GSR ENTERPRISES INC
A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL STUDY TO ASSESS THE EFFICACY, SAFETY, TOLERABILITY, PK, AND BIOMARKER EFFECTS OFPTC857IN ADULT SUBJECTS WITHAMYOTROPHIC LATERAL SCLEROSIS(CARDINALS) No dispute reported 06/30/2026 1249093187
Principal investigator 1 PTC Therapeutics, Inc. $1,800.00 02/18/2025 Non-covered Recipient Entity
GSR ENTERPRISES INC
A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL STUDY TO ASSESS THE EFFICACY, SAFETY, TOLERABILITY, PK, AND BIOMARKER EFFECTS OFPTC857IN ADULT SUBJECTS WITHAMYOTROPHIC LATERAL SCLEROSIS(CARDINALS) No dispute reported 06/30/2026 1249093189
Principal investigator 1 Novartis Pharmaceuticals Corporation $26,688.87 01/31/2025 Non-covered Recipient Entity
NEUROLOGY ASSOCIATES, PC
A phase 2, randomized, double-blind, placebo-controlled parallel group study of VHB937 in Amyotrophic Lateral Sclerosis (ALS) over 40 weeks followed by an Open-label Extension (ASTRALS) No dispute reported 06/30/2026 1190302395
Principal investigator 1 PTC Therapeutics, Inc. $124.80 01/30/2025 Non-covered Recipient Entity
GSR ENTERPRISES INC
A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL STUDY TO ASSESS THE EFFICACY, SAFETY, TOLERABILITY, PK, AND BIOMARKER EFFECTS OFPTC857IN ADULT SUBJECTS WITHAMYOTROPHIC LATERAL SCLEROSIS(CARDINALS) No dispute reported 06/30/2026 1249093161